$8.41
-0.97-10.34%
Last update: Nov 6, 4:17 PM
Verastem Inc (VSTM) Stock Price, Quote, News & History
VSTMNASDAQ
Verastem Oncology (NASDAQ:VSTM) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of Verastem (NASDAQ:VSTM) through any online brokerage.
Other companies in Verastem’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Verastem has a consensus price target of $15.43.
The stock price for Verastem (NASDAQ: VSTM) is $8.4 last updated November 6, 2026 at 4:17 PM EST.
There are no upcoming dividends for Verastem.
Verastem does not have any upcoming earnings scheduled.
There is no upcoming split for Verastem.
Verastem is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote...
